BEAT - Heartbeam, Inc.

Insider Purchase by Ferrari Richard (Dir)

1 Month
After Trade
Before Trade

Loading data...

Trade Summary

1 week ago, Ferrari Richard, serving as Dir at Heartbeam, Inc. (BEAT), purchased 57,500 shares at $0.80 per share, for a total transaction value of $46,000.00. Following this transaction, Ferrari Richard now holds 286,636 shares of BEAT.

This purchase represents a 25.00% increase in Ferrari Richard's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, April 16, 2026 and publicly disclosed via SEC Form 4 filing on Friday, April 24, 2026, 8 days after the trade was made.

Heartbeam, Inc. operates in the HEALTHCARE sector, specifically within the HEALTH INFORMATION SERVICES industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.

Ferrari Richard

Ferrari Richard

Dir

Richard Ferrari is a seasoned medical device entrepreneur and venture capitalist who joined the Board of Directors of HeartBeam, Inc. (NASDAQ: BEAT) in 2019 and was appointed Executive Director in June 2021.[[1]](https://ir.heartbeam.com/corporate-governance/board-committees)[[2]](https://rocketreach.co/richard-ferrari-email_24290940) He serves as Executive Chairman of HeartBeam and holds leadership roles including Chairman and CEO at Tenon Medical, Executive Chairman at Medlumics and PQ Bypass (acquired by Endologix), Vice-Chairman at ABS Interventional, and board member at Pulmonx Corp (public) and several other medtech startups.[[1]](https://ir.heartbeam.com/corporate-governance/board-committees)[[2]](https://rocketreach.co/richard-ferrari-email_24290940)[[7]](https://ir.tenonmed.com/corporate-governance/management/) Ferrari co-founded De Novo Ventures in 2000, where he has been Managing Director since, managing $650M focused on medical devices and biotechnology.[[1]](https://ir.heartbeam.com/corporate-governance/board-committees)[[3]](https://ir.heartbeam.com/news-events/press-releases/detail/6/heartbeam-appoints-rich-ferrari-and-marga-ortigas-wedekind) His career highlights include co-founding and leading CardioThoracic Systems (CTS) to a record-fast IPO and acquisition by Guidant for $350M, and serving as CEO of Cardiovascular Imaging Systems (CVIS), taken public and acquired by Boston Scientific for $125M.[[3]](https://ir.heartbeam.com/news-events/press-releases/detail/6/heartbeam-appoints-rich-ferrari-and-marga-ortigas-wedekind)[[4]](https://www.prnewswire.com/news-releases/heartbeam-appoints-rich-ferrari-and-marga-ortigas-wedekind-to-its-board-of-directors-300981209.html) He holds a BS from Ashland University and an MBA from the University of South Florida.[[1]](https://ir.heartbeam.com/corporate-governance/board-committees)[[4]](https://www.prnewswire.com/news-releases/heartbeam-appoints-rich-ferrari-and-marga-ortigas-wedekind-to-its-board-of-directors-300981209.html) Recently, as a Director of HeartBeam, he has engaged in stock transactions, owning approximately 244,789 shares valued at over $369K as of early 2025.[[5]](https://www.gurufocus.com/insider/131881/richard-m-ferrari)

View full insider profile →

Trade Price

$0.80

Quantity

57,500

Total Value

$46,000.00

Shares Owned

286,636

Trade Date

Thursday, April 16, 2026

9 days ago

SEC Filing Date

Friday, April 24, 2026

Filed 8 days after trade

HEALTHCAREHEALTH INFORMATION SERVICES

About Heartbeam, Inc.

Company Overview

No company information available
View news mentioning BEAT

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/5907756

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime